REDUCTION OF CALCIPHYLAXIS-RELATED INFECTIONS WITH HEXASODIUM FYTATE TREATMENT IN A RANDOMIZED, DOUBLE-BLIND, PHASE 3, PLACEBO-CONTROLLED TRIAL

  Back
REDUCTION OF CALCIPHYLAXIS-RELATED INFECTIONS WITH HEXASODIUM FYTATE TREATMENT IN A RANDOMIZED, DOUBLE-BLIND, PHASE 3, PLACEBO-CONTROLLED TRIAL
E-Poster Presentation

During the congress, E-Posters will be accessible to all participants on the congress website 24/7, as well as in the E-poster stations in the congress center. 

Preparing your E-Poster

Please review the E-Poster format requirements carefully when preparing your E-Poster. Should your E-Poster not meet the mentioned requirements, it may not be displayed as described above.

​E-Poster Submission Deadline

Please prepare and upload your E-Poster no later than January 23, 2025. After this date, you will no longer be able to prepare and upload your E-poster and it will not be displayed and accessible on the congress website.​

E-Poster Format Requirements
  • PDF file
  • Layout: Portrait (vertical orientation)
  • One page only (Dim A4: 210 x 297mm or PPT)
  • E-Poster can be prepared in PowerPoint (one (1) PowerPoint slide) but must be saved and submitted as PDF file.
  • File Size: Maximum file size is 2 Megabytes (2 MB)
  • No hyperlinks, animated images, animations, and slide transitions
  • Language: English
  • Include your abstract number
  • E-posters can include QR codes, tables and photos
https://storage.unitedwebnetwork.com/files/1099/950f682f2f9944d06f2720e3a05c0353.pdf
Smeeta
Sinha
14
Sagar Nigwekar sagarnigs@gmail.com Massachusetts General Hospital, Kidney Research Center Boston United States
Lisa Gould woundpastpres@gmail.com South Shore Hospital, Plastic Surgery Weymouth United States
Thomas Serena tserena@serenagroups.com SerenaGroup Research Foundation, n/a Cambridge United States
Sharon Moe smoe@iu.edu Indiana University School of Medicine, Division of Nephrology and Hypertension Indianapolis United States
George Aronoff George.Aronoff@davita.com DaVita Inc n/a Denver United States
Dinesh Chatoth Jeffrey.HymesMD@freseniusmedicalcare.com Fresenius Medical Care Holdings Inc n/a Waltham United States
Jeffrey Hymes Jeffrey.HymesMD@freseniusmedicalcare.com Fresenius Medical Care Holdings Inc n/a Waltham United States
Gabriela Alperovich Lehrer gabriela.alperovich@viforpharma.com Vifor Pharma Management AG, n/a Zurich Switzerland
Laurence Keller larry.keller.external@viforpharma.com Clinical Development Consultant, n/a Ann Arbor United States
Alex Gold alexander.m.gold@gmail.com Clinical Development Consultant, n/a Incline Village United States
Peter Szecsödy peter.szecsoedy@viforpharma.com Vifor Pharma Management AG, n/a Zurich Switzerland
Jana Radewonuk Jana.Radewonuk@cslbehring.com CSL Behring LLC, n/a King of Prussia United States
Joan Perelló joan.perello@sanifit.com Universitat de les Illes Balears n/a Palma de Mallorca Spain
Glenn Chertow gchertow@stanford.edu Stanford University School of Medicine Stanford United States